By Michael Erman and Bhanvi Satija NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program “negotiation with a gun[...]
Read more
Health
US extends certain COVID-related exclusions from China tariffs
(Reuters) – The U.S. Trade Representative’s Office said on Friday it was extending exclusions from tariffs for 77 of 81 Chinese medical product import categories related to the COVID-19 pa[...]
Read more
US lawmakers seek probe of how Elon Musk’s brain chip venture oversees animal experiments
By Rachael Levy WASHINGTON (Reuters) – U.S. lawmakers will ask regulators to investigate whether the make-up of a panel overseeing animal testing at Elon Musk’s brain-chip startup Neuralin[...]
Read more
Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
By Jennifer Rigby LONDON (Reuters) – New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, t[...]
Read more
GSK sells partial stake in spin-off firm Haleon at discount
(Reuters) -British drugmaker GSK on Friday said it sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about 804 million pounds ($1.01 billion). Haleon,[...]
Read more
Walgreens sells some AmerisourceBergen shares for $694 million
(Reuters) – Walgreens Boots Alliance, one of the largest U.S. pharmacies, said on Thursday it has sold some of its shares in drug distributor AmerisourceBergen Corp for $694 million and will pri[...]
Read more
Canada’s Sun Life beats profit estimates on strong insurance sales
(Reuters) -Canada’s second-biggest life insurer Sun Life Financial Inc on Thursday beat analysts’ estimates for first-quarter profit, powered by strong insurance sales at home and in the U[...]
Read more
Insulin makers testify on Capitol Hill over prices
By Ahmed Aboulenein WASHINGTON (Reuters) – Leaders of major insulin makers and pharmacy benefit managers (PBMs) traded blame for the life-saving drug’s high price on Wednesday while testif[...]
Read more
Bayer sees 2023 results at lower end of range as weedkiller prices drop
By Ludwig Burger FRANKFURT (Reuters) -Drug and pesticide maker Bayer said its 2023 results would likely come in at the lower end of its targeted range, hurt by cost inflation and a slump in prices of[...]
Read more